1
|
Active immunotherapy used alone for maintenance of patients with acute myeloid leukaemia.
|
Br Med J
|
1973
|
1.67
|
2
|
Lymphocyte reactivity in pregnancy.
|
Br Med J
|
1972
|
1.21
|
3
|
Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. II. Surface markers.
|
J Natl Cancer Inst
|
1980
|
1.15
|
4
|
Cytotoxicity against human leukaemic cells. I. Demonstration of antibody-dependent lymphocyte killing of human allogeneic myeloblasts.
|
Clin Exp Immunol
|
1973
|
1.08
|
5
|
Active immunotherapy in acute myelogenous leukaemia and the induction of second and subsequent remissions.
|
Br J Cancer
|
1978
|
1.05
|
6
|
Cell-mediated cytotoxicity as a result of immunotherapy in patients with acute myeloid leukaemia.
|
Br J Cancer
|
1976
|
0.97
|
7
|
Influence of HLA, ABO, and Rh(D) on survival after remission in acute myelogenous leukaemia.
|
Lancet
|
1977
|
0.96
|
8
|
Immunotherapy alone vs no maintenance treatment in acute myelogenous leukaemia.
|
Br J Cancer
|
1980
|
0.94
|
9
|
Plasmaphoresis and plasma exchange in the treatment of hyperlipaemia and xanthomatous neuropathy in patients with primary biliary cirrhosis.
|
Gut
|
1972
|
0.94
|
10
|
Immunological studies in acute myeloid leukaemia: PHA responsiveness and serum inhibitory factors.
|
Br J Cancer
|
1973
|
0.90
|
11
|
Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. I. Physical, cytogenetic, and growth characteristics.
|
J Natl Cancer Inst
|
1980
|
0.87
|
12
|
Response of remission lymphocytes to autochthonous leukaemic myeloblasts.
|
Br J Cancer
|
1976
|
0.87
|
13
|
Classification of cell lines derived from undifferentiated lymphomas according to their expression of complement and Epstein-Barr virus receptors: implications for the relationship between African and American Burkitt's lymphoma.
|
Clin Immunol Immunopathol
|
1982
|
0.80
|
14
|
Use of fluoresceinated complement-coated bacteria and sheep erythrocyte-antibody-complement complexes for identification of complement receptors on lymphoid cell lines: differences in binding characteristics between cell lines of normal and malignant origin.
|
J Natl Cancer Inst
|
1983
|
0.78
|
15
|
A new translocation associated with the Ph1 chromosome and an acute course of chronic granulocytic leukaemia.
|
Br J Cancer
|
1975
|
0.75
|
16
|
Long survival in acute myelogenous leukaemia.
|
Br Med J (Clin Res Ed)
|
1981
|
0.75
|
17
|
Receptors for human immunoglobulin on acute myeloid leukaemic leucocytes.
|
Br J Cancer
|
1976
|
0.75
|
18
|
Proceedings: Active immunotherapy in acute myeloid leukaemia.
|
Br J Cancer
|
1975
|
0.75
|
19
|
Induction of complement receptors in human cell lines derived from undifferentiated lymphomas.
|
Lab Invest
|
1981
|
0.75
|
20
|
Proceedings: Cell mediated cytotoxicity (CMC) in patients with acute myeloblastic leukaemia receiving immunotherapy.
|
Br J Cancer
|
1975
|
0.75
|
21
|
Proceedings: Surface immunological markers in acute myeloblastic leukaemia.
|
Br J Cancer
|
1975
|
0.75
|